DK96493D0 - Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden - Google Patents
Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaadenInfo
- Publication number
- DK96493D0 DK96493D0 DK93964A DK96493A DK96493D0 DK 96493 D0 DK96493 D0 DK 96493D0 DK 93964 A DK93964 A DK 93964A DK 96493 A DK96493 A DK 96493A DK 96493 D0 DK96493 D0 DK 96493D0
- Authority
- DK
- Denmark
- Prior art keywords
- self
- proteins
- protein
- procedure
- diseases
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000005875 antibody response Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037976 chronic inflammation Diseases 0.000 abstract 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/77—Ovalbumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK93964A DK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
KR1019960701052A KR100308444B1 (ko) | 1993-08-26 | 1994-08-25 | 이종 t-세포 에피토우프를 사용하여 자가 단백질에 대해항체반응을유도하는방법 |
AU76080/94A AU7608094A (en) | 1993-08-26 | 1994-08-25 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
JP50727895A JP3825041B2 (ja) | 1993-08-26 | 1994-08-25 | 外来t−細胞エピトープを補助として用いた、自己タンパク質に対する抗体応答の誘発 |
CA002170236A CA2170236C (fr) | 1993-08-26 | 1994-08-25 | Induction d'une reaction d'anticorps contre les auto-proteines grace aux epitopes de cellules t etrangeres |
EP94926106A EP0752886B1 (fr) | 1993-08-26 | 1994-08-25 | Procede d'induction de reactions immunitaires contre les proteines endogenes a l'aide d'epitopes de lymphocytes t exogenes |
ES94926106T ES2112559T3 (es) | 1993-08-26 | 1994-08-25 | Induccion de respuesta de anticuerpos contra proteinas endogenas con ayuda de epitopes de celulas t extrañas. |
PCT/DK1994/000318 WO1995005849A1 (fr) | 1993-08-26 | 1994-08-25 | Procede d'induction de reactions immunitaires contre les proteines endogenes a l'aide d'epitopes de lymphocytes t exogenes |
DK94926106.9T DK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
DE69408342T DE69408342T2 (de) | 1993-08-26 | 1994-08-25 | Die induktion der antikörperantwort gegen eigene proteine mit hilfe fremder t-zellepitope |
AT94926106T ATE162723T1 (de) | 1993-08-26 | 1994-08-25 | Die induktion der antikörperantwort gegen eigene proteine mit hilfe fremder t-zellepitope |
US08/955,373 US20020090379A1 (en) | 1993-08-26 | 1997-10-21 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
GR980400609T GR3026419T3 (en) | 1993-08-26 | 1998-03-20 | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
AU70091/98A AU707083B2 (en) | 1993-08-26 | 1998-06-11 | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK93964A DK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
Publications (1)
Publication Number | Publication Date |
---|---|
DK96493D0 true DK96493D0 (da) | 1993-08-26 |
Family
ID=8099485
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93964A DK96493D0 (da) | 1993-08-26 | 1993-08-26 | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
DK94926106.9T DK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94926106.9T DK0752886T3 (da) | 1993-08-26 | 1994-08-25 | Induktion af antistofsvar mod selv-proteiner ved hjælp af fremmede T-celleepitoper |
Country Status (12)
Country | Link |
---|---|
US (1) | US20020090379A1 (fr) |
EP (1) | EP0752886B1 (fr) |
JP (1) | JP3825041B2 (fr) |
KR (1) | KR100308444B1 (fr) |
AT (1) | ATE162723T1 (fr) |
AU (1) | AU7608094A (fr) |
CA (1) | CA2170236C (fr) |
DE (1) | DE69408342T2 (fr) |
DK (2) | DK96493D0 (fr) |
ES (1) | ES2112559T3 (fr) |
GR (1) | GR3026419T3 (fr) |
WO (1) | WO1995005849A1 (fr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410022B1 (en) | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
WO1996039168A1 (fr) | 1995-06-06 | 1996-12-12 | The Immune Response Corporation | Procede permettant d'accroitre le taux de cholesterol des lphd |
EP0866805A1 (fr) | 1995-12-12 | 1998-09-30 | Karolinska Innovations AB | PEPTIDE FIXANT LA SEQUENCE KLVFF DE L'AMYLOIDE $g(b) |
SI0975668T1 (sl) * | 1997-04-15 | 2007-02-28 | Pharmexa As | Modificirana molekula TNFalfa, DNA, ki kodira tako modificirano molekulo TNFalfa in cepivo, ki vsebuje tako modificirano molekulo TNFalfa in DNA |
US6319503B1 (en) * | 1998-02-19 | 2001-11-20 | Proteinix Company | Heat shock fusion-based vaccine system |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US6936249B1 (en) * | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6838269B1 (en) | 1998-04-15 | 2005-01-04 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
EP1541587A3 (fr) * | 1998-09-15 | 2007-06-20 | Pharmexa A/S | Méthode pour diminuer l'activité du ligand de l'ostéoprotégérine |
IL141588A0 (en) * | 1998-09-15 | 2002-03-10 | M & E Biotech As | Method for down-regulating osteoprotegerin ligand activity |
EP1502602A3 (fr) * | 1998-10-05 | 2006-05-17 | Pharmexa A/S | Procedes de vaccination therapeutique |
EA003634B1 (ru) * | 1998-10-05 | 2003-08-28 | Фармэкса А/С | Новые способы терапевтической вакцинации |
AU770802B2 (en) | 1998-10-21 | 2004-03-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Virus-like particles for the induction of autoantibodies |
US6913749B2 (en) | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
AU777952B2 (en) | 1999-04-23 | 2004-11-04 | Pharmexa A/S | Method for down-regulating IL5 activity |
US7060670B1 (en) | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
WO2000067777A1 (fr) * | 1999-05-07 | 2000-11-16 | Biofan Pty Ltd | Procede de prophylaxie et de traitement et agents utilisables dans ce procede |
CN1384757A (zh) | 1999-07-20 | 2002-12-11 | 法麦克萨有限公司 | 下调gdf-8活性的方法 |
KR20080017471A (ko) * | 2000-02-21 | 2008-02-26 | 파멕사 에이/에스 | 아밀로이드의 하향-조절을 위한 신규한 방법 |
DE60114157T2 (de) * | 2000-02-21 | 2006-06-29 | Pharmexa A/S | Verfahren zur herabregulierung von amyloid |
IL154219A0 (en) * | 2000-09-06 | 2003-07-31 | Pharmexa As | Method for down-regulating ige |
AU3941002A (en) | 2000-10-31 | 2002-06-03 | Zycos Inc | Cyp1b1 nucleic acids and methods of use |
US7097837B2 (en) | 2001-02-19 | 2006-08-29 | Pharmexa A/S | Synthetic vaccine agents |
US20030166589A1 (en) * | 2001-06-05 | 2003-09-04 | Nathan Karin | Method and pharmaceutical composition for the treatment of multiple sclerosis |
MY144532A (en) * | 2001-08-20 | 2011-09-30 | Lundbeck & Co As H | Novel method for down-regulation of amyloid |
HUP0402155A2 (hu) * | 2001-11-16 | 2005-01-28 | Pharmexa A/S | Multimer fehérjék új immunogén mimetikumai széleskörű T-sejt-epitóp-inszertekkel |
AU2003208314A1 (en) * | 2002-03-11 | 2003-09-22 | Pharmexa A/S | Novel application of vaccination against tnf-alpha |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
ATE519115T1 (de) | 2002-06-13 | 2011-08-15 | Merck Patent Gmbh | Verfahren für die identifizierung von allo- antigenen und ihre verwendung für krebstherapie und transplantation |
CA2505870A1 (fr) * | 2002-12-11 | 2004-06-24 | Soren Mouritsen | Epitopes uniques de ciblage |
WO2005025613A1 (fr) * | 2003-03-12 | 2005-03-24 | Rappaport Family Institute For Research In The Medical Sciences | Methodes d'identification de cibles biomoleculaires dans un but diagnostique et therapeutique |
ATE394676T1 (de) * | 2003-03-12 | 2008-05-15 | Rappaport Family Inst For Res | Verbindungen und verfahren zur diagnose von prostatakrebs |
US8017113B2 (en) | 2003-03-12 | 2011-09-13 | Rappaport Family Institute For Research In The Medical Sciences | Compositions and methods for diagnosing and treating an inflammation |
US20070031377A1 (en) * | 2003-03-28 | 2007-02-08 | Stany Depraetere | Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
EA008827B1 (ru) | 2003-06-25 | 2007-08-31 | Фармекса А/С | Очистка вариантов her-2 |
JP4751984B2 (ja) * | 2004-09-27 | 2011-08-17 | 順 西平 | Dnaワクチン |
JP2008523815A (ja) | 2004-12-15 | 2008-07-10 | エラン ファーマ インターナショナル リミテッド | 認知の改善における使用のためのヒト化アミロイドβ抗体 |
AU2006284248B2 (en) * | 2005-05-24 | 2010-10-07 | Neovacs | A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFalpha and a carrier protein |
CA2628546A1 (fr) * | 2005-11-09 | 2007-05-18 | Pharmexa A/S | Vaccins therapeutiques ciblant hmgb1 |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
WO2007137586A2 (fr) * | 2006-05-31 | 2007-12-06 | Pharmexa A/S | Insertion aléatoire de peptides |
EP2596801B1 (fr) | 2006-10-06 | 2018-05-02 | Bavarian Nordic A/S | Un virus vaccinia ankara modifié encodant un antigène de her-2 pour le traitement de cancer |
US8053231B2 (en) | 2007-04-03 | 2011-11-08 | Jun Nishihira | DNA vaccine |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
EP2182983B1 (fr) | 2007-07-27 | 2014-05-21 | Janssen Alzheimer Immunotherapy | Traitement de maladies amyloïdogéniques avec anti-abeta anticorps humanise |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
SE535982C2 (sv) * | 2009-12-15 | 2013-03-19 | Theravac Pharmaceuticals Ab | Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi |
CN105705522B (zh) * | 2013-05-14 | 2020-09-15 | 上海亨臻实业有限公司 | 针对低免疫原性蛋白的表位疫苗及其制法和用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3369466D1 (en) * | 1982-05-12 | 1987-03-05 | Harvard College | Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof |
US4684623A (en) * | 1985-05-02 | 1987-08-04 | The Board Of Trustees Of The Cetus Corporation | Use of tumor necrosis factor as a weight regulator |
US4772685A (en) * | 1985-10-02 | 1988-09-20 | Merck & Co., Inc. | Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
US5126399A (en) * | 1986-04-30 | 1992-06-30 | Board Of Regents, The University Of Texas System | Methods and compositions for the preparation and use of site-directed immunologic reagents |
EP0269455A3 (fr) * | 1986-11-28 | 1989-09-06 | Takeda Chemical Industries, Ltd. | Protéine fusionnée et hautement purifiée, comprenant un fragment humain IgE Fc et sa production |
NL8700927A (nl) * | 1987-04-16 | 1988-11-16 | Stichting Rega V Z W | Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing. |
GB8812214D0 (en) * | 1988-05-24 | 1988-06-29 | Hoffmann La Roche | Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope |
EP0420913B1 (fr) * | 1988-06-14 | 1995-11-15 | Cell Med, Inc. | Reactifs immunologiques cellulaires heterofonctionnels, vaccins les contenant et leurs modes d'utilisation |
US5260422A (en) * | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
EP0460076B1 (fr) * | 1989-02-24 | 1995-11-29 | The Regents Of The University Of California | Immunoglobulines ayant subi une manipulation genetique |
GB8905400D0 (en) * | 1989-03-09 | 1989-04-19 | Jonker Margreet | Medicaments |
JPH04503815A (ja) * | 1989-07-14 | 1992-07-09 | シェリング・コーポレーション | カルボキシル末端から誘導されたgm―csfのアンタゴニスト |
IT1231727B (it) * | 1989-08-11 | 1991-12-21 | Enrico Savoldi | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. |
US5969109A (en) * | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
CH683101A5 (de) * | 1990-09-18 | 1994-01-14 | Biotech Australia Pty Ltd | T-Zellen-Epitope. |
US5698195A (en) * | 1991-03-18 | 1997-12-16 | New York University Medical Center | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies |
AU634379B2 (en) * | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
SE9102808L (sv) * | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
WO1993023076A1 (fr) * | 1992-05-20 | 1993-11-25 | The Johns-Hopkins University | Therapie utilisant des recepteurs de substitution |
US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
-
1993
- 1993-08-26 DK DK93964A patent/DK96493D0/da not_active Application Discontinuation
-
1994
- 1994-08-25 AT AT94926106T patent/ATE162723T1/de not_active IP Right Cessation
- 1994-08-25 KR KR1019960701052A patent/KR100308444B1/ko not_active IP Right Cessation
- 1994-08-25 WO PCT/DK1994/000318 patent/WO1995005849A1/fr active IP Right Grant
- 1994-08-25 DK DK94926106.9T patent/DK0752886T3/da active
- 1994-08-25 EP EP94926106A patent/EP0752886B1/fr not_active Expired - Lifetime
- 1994-08-25 DE DE69408342T patent/DE69408342T2/de not_active Expired - Lifetime
- 1994-08-25 CA CA002170236A patent/CA2170236C/fr not_active Expired - Lifetime
- 1994-08-25 JP JP50727895A patent/JP3825041B2/ja not_active Expired - Fee Related
- 1994-08-25 ES ES94926106T patent/ES2112559T3/es not_active Expired - Lifetime
- 1994-08-25 AU AU76080/94A patent/AU7608094A/en not_active Abandoned
-
1997
- 1997-10-21 US US08/955,373 patent/US20020090379A1/en not_active Abandoned
-
1998
- 1998-03-20 GR GR980400609T patent/GR3026419T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995005849A1 (fr) | 1995-03-02 |
DE69408342D1 (de) | 1998-03-05 |
CA2170236C (fr) | 2007-11-06 |
CA2170236A1 (fr) | 1995-03-02 |
KR960704568A (ko) | 1996-10-09 |
DK0752886T3 (da) | 1998-05-04 |
ATE162723T1 (de) | 1998-02-15 |
EP0752886B1 (fr) | 1998-01-28 |
KR100308444B1 (ko) | 2001-11-30 |
AU7608094A (en) | 1995-03-21 |
ES2112559T3 (es) | 1998-04-01 |
EP0752886A1 (fr) | 1997-01-15 |
DE69408342T2 (de) | 1998-05-14 |
JPH09505031A (ja) | 1997-05-20 |
GR3026419T3 (en) | 1998-06-30 |
JP3825041B2 (ja) | 2006-09-20 |
US20020090379A1 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK96493D0 (da) | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden | |
RU2363707C2 (ru) | Искусственные белки с пониженной иммуногенностью | |
DK0851927T3 (da) | Forbindelser til immunterapi og diagnosticering af tuberkulose | |
ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
EP2311952A3 (fr) | Anticorps dirigé vers MART-1 protéine et ses fragments | |
NO20075902L (no) | Forbindelser for immunoterapi og diagnose av turberkolose og metoder for deres anvendelse | |
AR052377A2 (es) | Polipeptidos y polinucleotidos de neisseria meningitidis, un huesped unicelular, un metodo para producir una secuencia de adn, un metodo para producir un polipeptido, un metodo para aislar el antigeno, una composicion farmaceutica, uso de una proteina para producir una vacuna destinada para la preve | |
NZ331989A (en) | Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis | |
DK0469045T3 (da) | Syntetiske Pseudomonas aeruginosa pilinpeptider og beslægtede vacciner diagnostica | |
WO2004006861A3 (fr) | Peptides et procedes de criblage de vaccins a base de peptides immunogenes contre la maladie d'alzheimer | |
DK0701612T3 (da) | Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti | |
DE3650011D1 (de) | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND. | |
ATE201215T1 (de) | Malariapeptide | |
AU707083B2 (en) | Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes | |
MY105080A (en) | Heat-labile toxin b subunit fusion proteins. | |
Yamabe et al. | Antigenic group II chaperonin in Methanobrevibacter oralis may cross‐react with human chaperonin CCT | |
SE9001105D0 (sv) | New methods foer diagnosis of tuberculosis | |
DK0687300T3 (da) | LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation | |
DK0638316T3 (da) | Rekombinante adenovirusvacciner | |
ATE422503T1 (de) | Rekombinante polypeptide aus mycoplasma und impfstoffe | |
ES8800052A1 (es) | Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale | |
WO2000039301A3 (fr) | Procedes d'utilisation de molecules de mycobacterium tuberculosis en tant qu'adjuvants immunologiques | |
Mountford et al. | Fractionation of schistosome antigens by high performance electrophoretic chromatography and their screening for the ability to induce Th1 lymphocyte activity | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
Tollefsen et al. | T‐and B‐cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A0 | Application filed | ||
AHS | Application shelved for other reasons than non-payment |